Sigrid is a clinical-stage biotech Company driven by the vision to improve human health through material based innovations.
Location: Sweden, Stockholms kommun
Employees: 11-50
Total raised: $15.04M
Founded date: 2014
Investors 3
Date | Name | Website |
- | Almi Inves... | almi.se |
23.07.2023 | Irrus Inve... | irrusinves... |
- | Joyance Pa... | joyancepar... |
Funding Rounds 4
Date | Series | Amount | Investors |
01.11.2023 | - | $4M | - |
23.01.2023 | - | $1.04M | - |
11.11.2021 | - | $8.4M | - |
05.09.2019 | - | $1.6M | - |
Mentions in press and media 23
Date | Title | Description | Source |
25.01.2024 | Sigrid Therapeutics Announces Collaboration with Cencora to ... | Sigrid Therapeutics Announces Collaboration with Cencora to accelerate commercialization of revoluti... | news.cisio... |
14.11.2023 | Sigrid Therapeutics Launches the Glucose Stabiliser in the U... | Sigrid Therapeutics Launches the Glucose Stabiliser in the U.S. Tue, Nov 14, 2023 08:30 CET Report t... | news.cisio... |
13.11.2023 | Sigrid launches natural drug alternative technology for weig... | The glucose control supplement uses silica mineral to prevent breakdown of carbs and fats The assort... | vator.tv/n... |
01.11.2023 | Sweden-based Sigrid Therapeutics raises USD 4 million in fun... | Stockholm, Sweden-based Sigrid Therapeutics raised USD 4 million in an oversubscribed funding round.... | vcbay.news... |
31.10.2023 | Sigrid Therapeutics Raises $4M in Funding Round | Sigrid Therapeutics, a Stockholm, Sweden-based company which specializes in obesity and diabetes man... | finsmes.co... |
31.10.2023 | Sigrid Therapeutics Secures $4 Million in Oversubscribed Fun... | Sigrid Therapeutics Secures $4 Million in Oversubscribed Funding Round to Tap Into Booming Obesity a... | news.cisio... |
09.10.2023 | Sigrid Therapeutics Announces First Patient Treated with SiP... | Sigrid Therapeutics Announces First Patient Treated with SiPore21[®] Medical Device for Sustained Di... | news.cisio... |
16.08.2023 | Major Milestone Achieved: SiPore® Data Strengthens Path to W... | Major Milestone Achieved: SiPore® Data Strengthens Path to World's First Oral Medical Device for Blo... | news.cisio... |
09.05.2023 | Sigrid Therapeutics announces appointment of distinguished P... | Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advi... | news.cisio... |
14.03.2023 | Sigrid Therapeutics unveils SiPore® plaque blocker at IDS 20... | Sigrid Therapeutics unveils SiPore® plaque blocker at IDS 2023 Tue, Mar 14, 2023 08:30 CET Report th... | news.cisio... |
Show more